Distribution of Copper, Iron, and Zinc in the Retina, Hippocampus, and Cortex of the Transgenic APP/PS1 Mouse Model of Alzheimer’s Disease
Cells · 13.04.2023 · 12 (8) · 1144
DOI: 10.3390/cells12081144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 13.04.2023. Verfasst von Seyed Mostafa Hosseinpour Mashkani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedical Materials and Devices, School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, 15…. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UTS international scholarship, NHMRC-ARC Dementia Fellowship, Mason Foundation.
Themen: Demenz
Abstract (Originalsprache)
A mis-metabolism of transition metals (i.e., copper, iron, and zinc) in the brain has been recognised as a precursor event for aggregation of Amyloid-β plaques, a pathological hallmark of Alzheimer’s disease (AD). However, imaging cerebral transition metals in vivo can be extremely challenging. As the retina is a known accessible extension of the central nervous system, we examined whether changes in the hippocampus and cortex metal load are also mirrored in the retina. Laser ablation inductively coupled plasma-mass spectrometry (LA-ICP-MS) was used to visualise and quantify the anatomical distribution and load of Cu, Fe, and Zn in the hippocampus, cortex, and retina of 9-month-old Amyloid Precursor Protein/Presenilin 1 (APP/PS1, n = 10) and Wild Type (WT, n = 10) mice. Our results show a similar metal load trend between the retina and the brain, with the WT mice displaying significantly higher concentrations of Cu, Fe, and Zn in the hippocampus (p < 0.05, p < 0.0001, p < 0.01), cortex (p < 0.05, p = 0.18, p < 0.0001) and the retina (p < 0.001, p = 0.01, p < 0.01) compared with the APP/PS1 mice. Our findings demonstrate that dysfunction of the cerebral transition metals in AD is also extended to the retina. This could lay the groundwork for future studies on the assessment of transition metal load in the retina in the context of early AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biomedical Materials and Devices, School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, 15 Broadway, Sydney, NSW 2007, Australia.
- Hyphenated Mass Spectrometry Laboratory (HyMaS), School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, 15 Broadway, Sydney, NSW 2007, Australia.
- Synaptic Neurobiology Laboratory, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC 3000, Australia.
- Vision Science Group, Graduate School of Health (GSH), University of Technology Sydney, 15 Broadway, Sydney, NSW 2007, Australia.
ORCID-Profile: Seyed Mostafa Hosseinpour Mashkani, Olga Shimoni, S Mojtaba Golzan
Förderung
- UTS international scholarship
- NHMRC-ARC Dementia Fellowship
- Mason Foundation
Zitieren
APA
Hosseinpour Mashkani, S. M., Bishop, D. P., Raoufi-Rad, N., Adlard, P. A., Shimoni, O., & Golzan, S. M. (2023). Distribution of Copper, Iron, and Zinc in the Retina, Hippocampus, and Cortex of the Transgenic APP/PS1 Mouse Model of Alzheimer’s Disease. Cells, 12(8), 1144. https://doi.org/10.3390/cells12081144
Vancouver
Hosseinpour Mashkani SM, Bishop DP, Raoufi-Rad N, Adlard PA, Shimoni O, Golzan SM. Distribution of Copper, Iron, and Zinc in the Retina, Hippocampus, and Cortex of the Transgenic APP/PS1 Mouse Model of Alzheimer’s Disease. Cells. 2023;12(8):1144. doi:10.3390/cells12081144
BibTeX
@article{HosseinpourMashkani2023,
author = {Hosseinpour Mashkani, Seyed Mostafa and Bishop, David P and Raoufi-Rad, Newsha and Adlard, Paul A and Shimoni, Olga and Golzan, S Mojtaba},
title = {Distribution of Copper, Iron, and Zinc in the Retina, Hippocampus, and Cortex of the Transgenic APP/PS1 Mouse Model of Alzheimer’s Disease},
journal = {Cells},
year = {2023},
volume = {12},
number = {8},
pages = {1144},
doi = {10.3390/cells12081144}
}
EUVIMED